- Home
- OBT vs ANNX Comparison
OBT vs ANNX Comparison
Compare OBT & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBT
- ANNX
- Stock Information
- Founded
- OBT 1892
- ANNX 2011
- Country
- OBT United States
- ANNX United States
- Employees
- OBT N/A
- ANNX N/A
- Industry
- OBT Major Banks
- ANNX Biotechnology: Pharmaceutical Preparations
- Sector
- OBT Finance
- ANNX Health Care
- Exchange
- OBT Nasdaq
- ANNX Nasdaq
- Market Cap
- OBT 368.1M
- ANNX 334.1M
- IPO Year
- OBT N/A
- ANNX 2020
- Fundamental
- Price
- OBT $26.17
- ANNX $2.92
- Analyst Decision
- OBT Buy
- ANNX Strong Buy
- Analyst Count
- OBT 1
- ANNX 4
- Target Price
- OBT $29.00
- ANNX $13.00
- AVG Volume (30 Days)
- OBT 21.0K
- ANNX 1.9M
- Earning Date
- OBT 10-29-2025
- ANNX 11-10-2025
- Dividend Yield
- OBT 1.99%
- ANNX N/A
- EPS Growth
- OBT 18.38
- ANNX N/A
- EPS
- OBT 3.03
- ANNX N/A
- Revenue
- OBT $115,418,000.00
- ANNX N/A
- Revenue This Year
- OBT $19.86
- ANNX N/A
- Revenue Next Year
- OBT $7.20
- ANNX N/A
- P/E Ratio
- OBT $8.65
- ANNX N/A
- Revenue Growth
- OBT 17.75
- ANNX N/A
- 52 Week Low
- OBT $20.97
- ANNX $1.29
- 52 Week High
- OBT $32.43
- ANNX $6.93
- Technical
- Relative Strength Index (RSI)
- OBT 60.37
- ANNX 45.55
- Support Level
- OBT $25.50
- ANNX $2.66
- Resistance Level
- OBT $26.93
- ANNX $3.03
- Average True Range (ATR)
- OBT 0.81
- ANNX 0.24
- MACD
- OBT 0.25
- ANNX -0.04
- Stochastic Oscillator
- OBT 77.75
- ANNX 26.98
About OBT Orange County Bancorp Inc.
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.